Latest News about LBPS
Recent news which mentions LBPS
From InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
March 14, 2022
From Benzinga
95 Biggest Movers From Friday
March 14, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
March 11, 2022
From Benzinga
50 Stocks Moving In Friday's Mid-Day Session
March 11, 2022
From Benzinga
From Benzinga
4D Pharma restates first-half earnings due to accounting change
February 21, 2022
Tickers
LBPS
From MarketWatch
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
January 27, 2022
Tickers
LBPS
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 21, 2022
From Benzinga
From InvestorPlace
18 Stocks Moving in Friday's Pre-Market Session
January 21, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 07, 2022
From Benzinga
61 Biggest Movers From Yesterday
December 03, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 02, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 22, 2021
From Benzinga
38 Stocks Moving In Monday's Mid-Day Session
November 08, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 08, 2021
From Benzinga
From InvestorPlace
26 Stocks Moving in Monday's Pre-Market Session
November 08, 2021
From Benzinga
92 Biggest Movers From Friday
November 08, 2021
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 05, 2021
From Benzinga
44 Biggest Movers From Yesterday
October 05, 2021
From Benzinga
30 Stocks Moving In Monday's Mid-Day Session
October 04, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 04, 2021
From Benzinga
18 Stocks Moving in Monday's Pre-Market Session
October 04, 2021
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
September 30, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.